Skip to main content

Table 7 Pain

From: A systematic review and meta-analysis of risks and benefits with breast reduction in the public healthcare system: priorities for further research

Author

Year

Country

Study design

Number of patients

Withdrawals-dropouts

Intervention

Breast reduction

Mean (SD)

Control

No surgery

Mean (SD)

P values denote intergroup difference if not otherwise depicted

Comments

Directness*

Study limitations*

Precision*

Iwuagwu

2006

UK [31]

RCT

73

I: 36

C: 37

0

EQ-5D

Pain:

Baseline: 1.88 (0.46)

4 months: 1.46 (0.57)

EQ-5D

Pain:

Baseline: 1.94 (0.52)

4 months: 2.05 (0.52)

p < 0.001

MD 0.59

EuroQol EQ-5D: The European Quality of Life-5 Dimensions

Pain assessment scores are part of the questionnaire. Lower score = less pain, range 1–3

?

?

?

Saariniemi

2008

Finland [34]

RCT

82

I: 40

C: 42

18

I: 11

C: 7

FBAS

11.8 (SD NR)

FBAS

57.9 (SD NR)

MD − 46.1 (95% CI − 49.8 to

− 40.7), p < 0.0001

FBAS: Finnish Breast Associated Symptoms questionnaire (Higher scores = more symptoms, range 0–100)

?/ + 

?

 + 

    

FPQ

7.0 (SD NR)

FPQ

26.5 (SD NR)

MD − 19.5 (95% CI − 25.2 to

− 14.3), p < 0.0001

FPQ: Finnish Pain Questionnaire (Higher scores = more pain, range 0–100)

   

Freire

2007

Brazil [37]

RCT

100

I: 50

C: 50

8

I: 4

C: 4

VAS:

Lower back

Baseline: 5.7 (2.7)

6 months: 1.3 (2.5)

VAS:

Lower back pain

Baseline: 6.0 (3.3)

6 months: 5.3 (2.8)

p < 0.001

VAS: Visual analogue scale (0: No pain, 10: Intense pain

Same cohort as Neto et al. [36]. Lower back pain data identical

 + 

?/−

?

    

Shoulders

Baseline: 6.1 (2.7)

6 months: 1.1 (1.8)

p < 0.001 (intragroup difference)

Shoulders

Baseline: 6.2 (3.2)

6 months: 6.9 (2.6)

p < 0.001

NS (intragroup difference)

A MID of 0.9 has been suggested for VAS [66]

   
    

Neck

Baseline: 5.2 (2.9)

6 months: 0.9 (1.3)

p < 0.001 (intragroup difference)

Neck

Baseline: 4.7 (3.6)

6 months: 5.1 (3.1)

p < 0.001

NS (intragroup difference)

    

Hermans

2005

Netherlands [43]

Non-randomized controlled study

165

I: 94

C: 71

10

I: 10

C: 0

SF-36

Pain: 77.65

SF-36

Pain: 57.00 p < 0.001

MD 21

SF-36: Short Form-36 Health survey (higher score = better health, range 0–100)

?

?/−

?

    

EQ-5D

Pain:

No problems: 51.2%

Some problems: 44.0% Many problems: 4.8%

EQ-5D

Pain:

No problems: 14.1%

Some problems: 78.9%

Many problems: 7.0%

p < 0.001

EQ-5D: The European Quality of Life-5 Dimensions (mobility, self-care, usual activities, pain/discomfort, anxiety/depression). Only 2 dimensions stated in article

   
    

DAS-59

Pain:

Almost never: 68%

Sometimes: 22%

Always/Often: 10%

DAS-59

Pain:

Almost never: 2%

Sometimes: 18%

Always/Often: 80%

p < 0.001

DAS-59: Derriford Appearance Scale 59. Higher scores indicate greater problems

Pain scores were all part of QoL-questionnaires

   
  1. NR not reported, NS no significance, EQ-5D The European Quality of Life-5 Dimensions, FBAS Finnish Breast Associated Symptoms questionnaire, FPQ Finnish Pain Questionnaire, VAS visual analogue scale, SF-36 Short Form-36 Health survey, DAS-59 Derriford Appearance Scale 59
  2. * + No or minor problems; ? Some problems; - Major problems